Confident Investing Starts Here:
- Quickly and easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks straight to you inbox with TipRanks' Smart Value Newsletter
An update from Intelligent Bio Solutions ( (INBS) ) is now available.
On May 13, 2025, Intelligent Bio Solutions Inc. announced its financial results for the fiscal third quarter and nine months ended March 31, 2025. The company reported a 20% sequential quarterly revenue growth and a 91% year-over-year increase in quarterly gross profit, driven by higher-margin cartridge sales, which now account for 58% of total sales. The company added 35 new accounts, bringing its total active accounts to over 450, and continued its international growth strategy with expansions in Europe and the Middle East. The company also announced a reduction in losses due to improved cost control and operational efficiency, and introduced multilingual functionality to support global scalability.
Spark’s Take on INBS Stock
According to Spark, TipRanks’ AI Analyst, INBS is a Neutral.
INBS shows potential with strong revenue growth and strategic corporate developments, such as securing a U.S. patent and forming key partnerships. However, persistent negative earnings, cash flow issues, and weak technical indicators weigh heavily on the overall stock score. The company needs to improve profitability and cash generation to enhance its financial position. The negative valuation metrics also pose a significant concern for potential investors.
To see Spark’s full report on INBS stock, click here.
More about Intelligent Bio Solutions
Intelligent Bio Solutions Inc. is a medical technology company specializing in intelligent, rapid, non-invasive testing solutions. The company is known for its Intelligent Fingerprinting Drug Screening System, which utilizes fingerprint sweat analysis for drug testing. This technology is particularly useful in safety-critical industries such as construction, manufacturing, engineering, transport, and logistics.
Average Trading Volume: 140,788
Technical Sentiment Signal: Sell
Current Market Cap: $8.31M
For a thorough assessment of INBS stock, go to TipRanks’ Stock Analysis page.